Invention Grant
- Patent Title: Treatment of type 1 diabetes
-
Application No.: US16610658Application Date: 2018-05-04
-
Publication No.: US11517754B2Publication Date: 2022-12-06
- Inventor: Arun Sridhar , Philippe Blancou , Nicolas Glaichenhaus
- Applicant: Galvani Bioelectronics Limited , Centre Nationale de La Recherche Scientifique , Université Côte d'Azur
- Applicant Address: GB Middlesex; FR Paris; FR Nice
- Assignee: Galvani Bioelectronics Limited,Centre Nationale de La Recherche Scientifique,Université Côte d'Azur
- Current Assignee: Galvani Bioelectronics Limited,Centre Nationale de La Recherche Scientifique,Université Côte d'Azur
- Current Assignee Address: GB Middlesex; FR Paris; FR Nice
- Agency: Banner & Witcoff, Ltd.
- Priority: GB1707207 20170505
- International Application: PCT/EP2018/061563 WO 20180504
- International Announcement: WO2018/202877 WO 20181108
- Main IPC: A61N1/36
- IPC: A61N1/36 ; A61N1/05
Abstract:
Modulation of neural signaling of a pancreas-related sympathetic nerve is capable of improving glycaemic control by inhibiting T cell activation or migration to the pancreas, and hence providing a way of treating or preventing type 1 diabetes.
Public/Granted literature
- US20210339025A1 TREATMENT OF TYPE 1 DIABETES Public/Granted day:2021-11-04
Information query
